ETHZilla Corporation Pivots to Ethereum Asset Management, Raises $565 Million

ETHZilla Corporation announced a major shift in its business focus, transitioning from biotech to Ethereum asset management. The company officially changed its Nasdaq ticker to ‘ETHZ’ on August 18, 2025, marking a significant departure from its previous identity as 180 Life Sciences Corp. This move involves a $565 million capital infusion through private placements and convertible bonds, with leading crypto firms like Polychain Capital and Electric Capital backing the strategy. This investment will fuel ETHZilla’s operations in Ethereum treasury management, with the company already holding approximately 94,675 ETH valued at around $419 million.